RecruitingNot applicableNCT07156214
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
Studying Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Catholic University of the Sacred Heart
- Principal Investigator
- Gabriella SilvestriCatholic University of the Sacred Heart
- Intervention
- Assessment of markers of oxidative stress in peripheral blood samples(other)
- Enrollment
- 50 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2024 – 2026
Study locations (2)
- Alma Mater Studiorum University of Bologna, Bologna, Italy
- Department of Neuroscience, Roma, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07156214 on ClinicalTrials.govOther trials for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT0754382224VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAsChildren's Hospital of Philadelphia
- ACTIVE NOT RECRUITINGPHASE2NCT0754964624VA021; VATCH Trametinib for Ras/MAPK Pathway VAsChildren's Hospital of Philadelphia
- RECRUITINGNANCT06817707Evaluation of Urinary Dysfunction in CANVAS PatientsCentre Hospitalier Universitaire de Nice
- RECRUITINGNCT05177809RFC1 Natural History StudyProf. Dr. Matthis Synofzik
See all trials for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome →